Hattiesburg, MS, United States of America

Matthew Garrett Donahue

This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 6 CIPO patents and 13 EPO patents. Top assignees: Janssen Pharmaceutica Nv, Ortho-Clinical Diagnostics, Inc. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Garrett Donahue. Retrieved from https://idiyas.com/inventor/matthew-garrett-donahue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 4)

% Patents Active = 64.7

CIPO Patents = 6

EPO Patents = 13 (Patent Applications = 13)

Average Co-Inventor Count = 8.2

ph-index = 5

Forward Citations = 85(Granted Patents)

Location History:

Warrington, PA (US) (2016)
Hattiesburg, MS (US) (2017 - 2022)

Company Filing History:

17 out of 2,101

Janssen Pharmaceutica Nv

patents

3 out of 172

Ortho-Clinical Diagnostics, Inc

patents

where one patent can have more than one assignee

Years Active: 2016-2022

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11226345 - Antibodies to olanzapine haptens and use thereof (2022-01-18),

2. 11214566 - Substituted pyridine derivatives useful as C-FMS kinase inhibitors (2022-01-04),

3. 11104742 - Antibodies to quetiapine and use thereof (2021-08-31),

4. 11046786 - Antibodies to olanzapine and use thereof (2021-06-29),

5. 10800764 - Substituted pyridine derivatives useful as C-FMS kinase inhibitors (2020-10-13),

6. 10712353 - Antibodies to olanzapine haptens and use thereof (2020-07-14),

7. 10465013 - Antibodies to quetiapine haptens and use thereof (2019-11-05),

8. 10435478 - Antibodies to quetiapine and use thereof (2019-10-08),

9. 10344098 - Antibodies to olanzapine and use thereof (2019-07-09),

10. 10288631 - Antibodies to quetiapine and use thereof (2019-05-14),

11. 10071991 - Substituted pyridine derivatives useful as c-fms kinase inhibitors (2018-09-11),

12. 9850318 - Antibodies to quetiapine haptens and use thereof (2017-12-26),

13. 9611259 - Substituted pyridine derivatives useful as C-FMS kinase inhibitors (2017-04-04),

14. 9494608 - Antibodies to olanzapine and use thereof (2016-11-15),

15. 9410972 - Antibodies to quetiapine and use thereof (2016-08-09),

Title: Matthew Garrett Donahue - Innovative Inventor from Hattiesburg

Introduction: Matthew Garrett Donahue is a talented inventor based in Hattiesburg, Mississippi, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Matthew Garrett Donahue holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced robotics, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in mechanical engineering and a passion for pushing the boundaries of what is possible, Matthew Garrett Donahue has successfully brought numerous cutting-edge inventions to life, revolutionizing industries along the way.

Collaborations: Throughout his career, Matthew Garrett Donahue has collaborated with leading research institutions, universities, and innovative companies to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Matthew Garrett Donahue's relentless pursuit of innovation and his commitment to creating a positive impact on society through his inventions make him a truly inspiring figure in the world of technology and invention.

Profile summary based on public USPTO records.